{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:06:33Z","timestamp":1792785993575,"version":"4.5.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"8","funder":[{"name":"Department of Veterans Affairs Medical Centers"},{"name":"White River Junction"},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32-CA009314"],"award-info":[{"award-number":["T32-CA009314"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA006973"],"award-info":[{"award-number":["P30CA006973"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Women with major depressive disorder (MDD) who develop breast cancer have higher breast cancer recurrence compared with women without MDD. The reason for the higher recurrence is hypothesized to be multifactorial. We sought to determine whether nonadherence to antidepressants is associated with increased recurrence among women with MDD and breast cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We established a retrospective cohort of 6051 women (aged\u2009\u2265\u200918\u2009years), with and without MDD, who were diagnosed with early-stage invasive breast cancer between 2010 and 2019 with follow-up through 2022 using medical record data from the United States Veterans Affairs Healthcare System. We assessed antidepressant adherence in women with MDD more than 2 years before breast cancer diagnosis. We evaluated multiple adherence thresholds (proportion of medication days covered), ranging from \u226520% to 100%. We used multivariable competing-risks regression to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for the statistical interaction between MDD and antidepressant adherence on recurrence, adjusting for sociodemographic, clinical, and prognostic factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among women with MDD and breast cancer (N\u2009=\u20091754), 94% initiated an antidepressant. A threshold of 60% was the minimum adherence level for there to be a statistically meaningful difference in recurrence between nonadherent and adherent women with MDD. Thirty-nine percent were nonadherent at this threshold. The association between MDD and recurrence was highest among women who did not use antidepressants (HR\u2009=\u20092.20, 95% CI\u2009=\u20091.54 to 3.15), followed by women who were nonadherent (HR\u2009=\u20091.52, 95% CI\u2009=\u20091.24 to 1.86), and lowest among women who were adherent (HR\u2009=\u20091.19, 95% CI\u2009=\u20090.99 to 1.42).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Adherence to antidepressants could potentially reduce recurrence in patients with breast cancer and MDD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jnci\/djag076","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T10:24:21Z","timestamp":1774088661000},"page":"1469-1477","source":"Crossref","is-referenced-by-count":1,"title":["Antidepressant adherence and breast cancer recurrence risk in women with major depressive disorder: a retrospective cohort"],"prefix":"10.1093","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6140-4250","authenticated-orcid":false,"given":"Maya","family":"Aboumrad","sequence":"first","affiliation":[{"name":"White River Junction Veterans Affairs Medical Center , White River Junction, VT,","place":["United States"]},{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health , Baltimore, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5100-172X","authenticated-orcid":false,"given":"Corinne","family":"Joshu","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health , Baltimore, MD,","place":["United States"]},{"name":"Johns Hopkins Sidney Kimmel Comprehensive Cancer Center , Baltimore, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W","family":"Jackson","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health , Baltimore, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0582-8005","authenticated-orcid":false,"given":"Kala","family":"Visvanathan","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health , Baltimore, MD,","place":["United States"]},{"name":"Johns Hopkins Sidney Kimmel Comprehensive Cancer Center , Baltimore, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,21]]},"reference":[{"key":"2026081005023404300_djag076-B1","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1093\/jnci\/djae287","article-title":"Impact of major depressive disorder on breast cancer outcomes: a national retrospective cohort study","volume":"117","author":"Aboumrad","year":"2025","journal-title":"J Natl Cancer Inst"},{"key":"2026081005023404300_djag076-B2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s10549-016-3928-3","article-title":"Effect of selective serotonin reuptake inhibitors use on endocrine therapy adherence and breast cancer mortality: a population-based study","volume":"159","author":"Valachis","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"2026081005023404300_djag076-B3","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/da.22938","article-title":"Adherence to antidepressant medications is associated with reduced premature mortality in patients with cancer: a nationwide cohort study","volume":"36","author":"Shoval","year":"2019","journal-title":"Depress Anxiety"},{"key":"2026081005023404300_djag076-B4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s10549-015-3471-7","article-title":"Depression as a predictor of adherence to adjuvant endocrine therapy (AET) in women with breast cancer: a systematic review and meta-analysis","volume":"152","author":"Mausbach","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"2026081005023404300_djag076-B5","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1200\/JCO.2014.59.3673","article-title":"Predictors of discontinuation of adjuvant hormone therapy in patients with breast cancer","volume":"33","author":"He","year":"2015","journal-title":"J Clin Oncol"},{"key":"2026081005023404300_djag076-B6","doi-asserted-by":"publisher","first-page":"431","DOI":"10.18553\/jmcp.2023.29.4.431","article-title":"Trends, characteristics, race, and ethnicity associated with nonadherence to antidepressants among breast cancer survivors with depression","volume":"29","author":"Chang","year":"2023","journal-title":"J Manag Care Spec Pharm"},{"key":"2026081005023404300_djag076-B7","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.3892\/ol.2015.2944","article-title":"Depression in cancer patients: pathogenesis, implications and treatment","volume":"9","author":"Smith","year":"2015","journal-title":"Oncol Lett"},{"key":"2026081005023404300_djag076-B8","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1001\/jama.286.17.2143","article-title":"Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms","volume":"286","author":"Singletary","year":"2001","journal-title":"JAMA"},{"key":"2026081005023404300_djag076-B9","doi-asserted-by":"publisher","first-page":"5349","DOI":"10.1002\/cncr.24561","article-title":"Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis","volume":"115","author":"Satin","year":"2009","journal-title":"Cancer"},{"key":"2026081005023404300_djag076-B10","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.2105\/AJPH.2014.302490","article-title":"Racial\/ethnic and socioeconomic disparities in endocrine therapy adherence in breast cancer: a systematic review","volume":"105","author":"Roberts","year":"2015","journal-title":"Am J Public Health"},{"key":"2026081005023404300_djag076-B11","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1017\/S0033291709992285","article-title":"Depression and cancer mortality: a meta-analysis","volume":"40","author":"Pinquart","year":"2010","journal-title":"Psychol Med"},{"key":"2026081005023404300_djag076-B12","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1017\/S0033291719001454","article-title":"Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels","volume":"49","author":"Osimo","year":"2019","journal-title":"Psychol Med"},{"key":"2026081005023404300_djag076-B13","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1089\/pop.2014.0146","article-title":"Impact of preexisting mental illnesses on receipt of guideline-consistent breast cancer treatment and health care utilization","volume":"18","author":"Mahabaleshwarkar","year":"2015","journal-title":"Popul Health Manag"},{"key":"2026081005023404300_djag076-B14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2147\/BCTT.S129746","article-title":"Recent insights into cigarette smoking as a lifestyle risk factor for breast cancer","volume":"9","author":"Kispert","year":"2017","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"2026081005023404300_djag076-B15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1136\/jech-2019-212311","article-title":"Stage at diagnosis and survival in patients with cancer and a pre-existing mental illness: a meta-analysis","volume":"74","author":"Davis","year":"2020","journal-title":"J Epidemiol Community Health"},{"key":"2026081005023404300_djag076-B16","doi-asserted-by":"publisher","first-page":"5075","DOI":"10.1007\/s00520-020-05585-9","article-title":"Adherence to adjuvant endocrine therapy among breast cancer survivors: a systematic review and meta-synthesis of the qualitative literature using grounded theory","volume":"28","author":"AlOmeir","year":"2020","journal-title":"Support Care Cancer"},{"key":"2026081005023404300_djag076-B17","doi-asserted-by":"publisher","first-page":"e5136","DOI":"10.1210\/clinem\/dgab443","article-title":"Associations between antidepressant use and advanced diabetes outcomes in patients with depression and diabetes mellitus","volume":"106","author":"Wu","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026081005023404300_djag076-B18","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1080\/03007995.2017.1347092","article-title":"Impact of adherence to antidepressants on healthcare outcomes and costs among patients with type 2 diabetes and comorbid major depressive disorder","volume":"33","author":"Vega","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"2026081005023404300_djag076-B19","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1001\/jamapsychiatry.2017.3047","article-title":"Adherence to depression treatment in primary care: a randomized clinical trial","volume":"74","author":"Sirey","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"2026081005023404300_djag076-B20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13643-020-1274-3","article-title":"Psychotropic medication non-adherence and its associated factors among patients with major psychiatric disorders: a systematic review and meta-analysis","volume":"9","author":"Semahegn","year":"2020","journal-title":"Syst Rev"},{"key":"2026081005023404300_djag076-B21","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.euroneuro.2017.08.428","article-title":"Low adherence to antidepressants is associated with increased mortality following stroke: a large nationally representative cohort study","volume":"27","author":"Krivoy","year":"2017","journal-title":"Eur Neuropsychopharmacol"},{"key":"2026081005023404300_djag076-B22","doi-asserted-by":"publisher","first-page":"e2332579","DOI":"10.1001\/jamanetworkopen.2023.32579","article-title":"Antidepressant use and mortality among patients with hepatocellular carcinoma","volume":"6","author":"Huang","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2026081005023404300_djag076-B23","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s40261-018-0642-4","article-title":"Adherence to antidepressants and mortality in elderly patients with cardiovascular disease","volume":"38","author":"Biffi","year":"2018","journal-title":"Clin Drug Invest"},{"key":"2026081005023404300_djag076-B24","first-page":"62","article-title":"Antidepressants in patients with advanced cancer: when they\u2019re warranted and how to choose therapy","volume":"33","author":"Ahmed","year":"2019","journal-title":"Oncology (Williston Park)"},{"key":"2026081005023404300_djag076-B25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3390\/cancers13010107","article-title":"Potentially modifiable factors associated with adherence to adjuvant endocrine therapy among breast cancer survivors: a systematic review","volume":"13","author":"Toivonen","year":"2020","journal-title":"Cancers"},{"key":"2026081005023404300_djag076-B26","doi-asserted-by":"publisher","first-page":"1320159","DOI":"10.3389\/fpubh.2024.1320159","article-title":"Effectiveness of interventions to improve adherence to antidepressant medication in patients with depressive disorders: a cluster randomized controlled trial","volume":"12","author":"del Pino-Sede\u00f1o","year":"2024","journal-title":"Front Public Health"},{"key":"2026081005023404300_djag076-B27","doi-asserted-by":"publisher","first-page":"e221875","DOI":"10.1001\/jamanetworkopen.2022.1875","article-title":"Electronic population-based depression detection and management through universal screening in the Veterans Health Administration","volume":"5","author":"Leung","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2026081005023404300_djag076-B28","volume-title":"VA\/DoD Clinical Practice Guideline for Management of Major Depressive Disorder","author":"The Management of Major Depressive Disorder Work Group","year":"2009"},{"key":"2026081005023404300_djag076-B29","doi-asserted-by":"publisher","first-page":"e1883","DOI":"10.7205\/MILMED-D-16-00371","article-title":"Cancer incidence among patients of the US Veterans Affairs Health Care System: 2010 update","volume":"182","author":"Zullig","year":"2017","journal-title":"Mil Med"},{"key":"2026081005023404300_djag076-B30","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"2026081005023404300_djag076-B31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12888-018-1990-6","article-title":"Validation of a case definition for depression in administrative data against primary chart data as a reference standard","volume":"19","author":"Doktorchik","year":"2019","journal-title":"BMC Psychiatry"},{"key":"2026081005023404300_djag076-B32","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s40263-017-0417-0","article-title":"Adherence and persistence across antidepressant therapeutic classes: a retrospective claims analysis among insured US patients with major depressive disorder (MDD)","volume":"31","author":"Keyloun","year":"2017","journal-title":"CNS Drugs"},{"key":"2026081005023404300_djag076-B33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10654-022-00921-1","article-title":"Circulating vitamin D and breast cancer risk: an international pooling project of 17 cohorts","volume":"38","author":"Visvanathan","year":"2023","journal-title":"Eur J Epidemiol"},{"key":"2026081005023404300_djag076-B34","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/s0895-4356(02)00585-1","article-title":"How to measure comorbidity: a critical review of available methods","volume":"56","author":"De Groot","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"2026081005023404300_djag076-B35","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1748-0361.2009.00200.x","article-title":"Do older rural and urban veterans experience different rates of unplanned readmission to VA and non-VA hospitals?","volume":"25","author":"Weeks","year":"2009","journal-title":"J Rural Health"},{"key":"2026081005023404300_djag076-B36","doi-asserted-by":"publisher","first-page":"469","DOI":"10.7205\/MILMED-D-15-00094","article-title":"Veterans Affairs health system enrollment and health care utilization after the Affordable Care Act: initial insights","volume":"181","author":"Silva","year":"2016","journal-title":"Mil Med"},{"key":"2026081005023404300_djag076-B37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/20009666.2016.1264696","article-title":"Prevalence and risk factors of heart failure in the USA: NHANES 2013\u20132014 epidemiological follow-up study","volume":"7","author":"Komanduri","year":"2017","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"2026081005023404300_djag076-B38","doi-asserted-by":"publisher","first-page":"837","DOI":"10.7326\/0003-4819-157-12-201212180-00003","article-title":"Associations between reduced hospital length of stay and 30-day readmission rate and mortality: 14-year experience in 129 Veterans Affairs hospitals","volume":"157","author":"Kaboli","year":"2012","journal-title":"Ann Intern Med"},{"key":"2026081005023404300_djag076-B39","doi-asserted-by":"publisher","first-page":"e2024345","DOI":"10.1001\/jamanetworkopen.2020.24345","article-title":"Evaluation of changes in Veterans Affairs Medical Centers\u2019 mortality rates after risk adjustment for socioeconomic status","volume":"3","author":"Trivedi","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2026081005023404300_djag076-B40","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1038\/s41380-020-00865-6","article-title":"Prognostic value of depression and anxiety on breast cancer recurrence and mortality: a systematic review and meta-analysis of 282,203 patients","volume":"25","author":"Wang","year":"2020","journal-title":"Mol Psychiatry"},{"key":"2026081005023404300_djag076-B41","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1097\/PSY.0000000000000942","article-title":"Major depression and survival in people with cancer","volume":"83","author":"Walker","year":"2021","journal-title":"Psychosom Med"},{"key":"2026081005023404300_djag076-B42","doi-asserted-by":"publisher","first-page":"18334","DOI":"10.1038\/s41598-019-54677-y","article-title":"Association of pre-existing depression with all-cause, cancer-related, and noncancer-related mortality among 5-year cancer survivors: a population-based cohort study","volume":"9","author":"Ko","year":"2019","journal-title":"Sci Rep"},{"key":"2026081005023404300_djag076-B43","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.breast.2022.01.012","article-title":"Factors influencing five-year adherence to adjuvant endocrine therapy in breast cancer patients: a systematic review","volume":"62","author":"Yussof","year":"2022","journal-title":"Breast"},{"key":"2026081005023404300_djag076-B44","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.2147\/NDT.S213839","article-title":"The association between cortisol: C-reactive protein ratio and depressive fatigue is a function of CRP rather than cortisol","volume":"15","author":"Sharpley","year":"2019","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2026081005023404300_djag076-B45","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1745-0179-3-2","article-title":"Depression in cancer patients: a critical review","volume":"3","author":"Pasquini","year":"2007","journal-title":"Clin Pract Epidemiol Ment Health"},{"key":"2026081005023404300_djag076-B46","doi-asserted-by":"publisher","first-page":"e442","DOI":"10.3399\/BJGP.2023.0406","article-title":"Interventions to improve medication adherence in adults with mental\u2013physical multimorbidity in primary care: a systematic review","volume":"74","author":"Lammila-Escalera","year":"2024","journal-title":"Br J Gen Pract"},{"key":"2026081005023404300_djag076-B47","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1001\/jama.2018.19271","article-title":"Interventions to improve medication adherence: a review","volume":"320","author":"Kini","year":"2018","journal-title":"JAMA"},{"key":"2026081005023404300_djag076-B48","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1158\/1055-9965.EPI-17-0862","article-title":"Studying the effects of nonindicated medications on cancer: etiologic versus action-focused analysis of epidemiologic data","volume":"27","author":"Jackson","year":"2018","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2026081005023404300_djag076-B49","doi-asserted-by":"publisher","first-page":"402","DOI":"10.7326\/ANNALS-24-01871","article-title":"The Target Trial Framework for causal inference from observational data: why and when is it helpful?","volume":"178","author":"Hern\u00e1n","year":"2025","journal-title":"Ann Intern Med"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djag076\/67457952\/djag076.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/118\/8\/1469\/67457952\/djag076.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/118\/8\/1469\/67457952\/djag076.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T09:02:37Z","timestamp":1786352557000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/118\/8\/1469\/8533549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,21]]},"references-count":49,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,3,21]]},"published-print":{"date-parts":[[2026,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djag076","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,3,21]]}}}